Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with active moderate to severe Ulcerative Colitis, confirmed by an endoscopy (a camera procedure to look inside the bowel).
- Your doctor has already decided, as part of your normal care, to start you on a medication called Upadacitinib — this decision must be made independently of this study.
- You are able to understand and communicate with the research team and are willing to follow the study requirements.
- You are willing to continue providing information for the study even if you stop taking Upadacitinib.
Who may not be able to join:
- You have a medical reason why you cannot take Upadacitinib (confirm with trial site).
- You have previously taken a type of medication called a JAK inhibitor (a group of drugs that work by blocking certain proteins involved in inflammation — confirm with trial site if you are unsure whether any medication you have taken falls into this category).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: ABBVIE INC., AbbVie
Phone: 49 611 1720 1520
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of participants achieving symptomatic remission per partial adapted Mayo score among those who achieved clinical response and/or intestinal ultrasound (IUS) response at week 8 of upadacitinib (UPA) induction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.